FDA Approved: HEMLIBRA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hemlibra (emicizumab) submitted by Genentech, Inc. The action updates the product’s labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Hemlibra (emicizumab)

Snippet

SUPPL AP for HEMLIBRA (EMICIZUMAB)